Molecular Forecaster Participates in the $165-million CFREF grant awarded to McGill University to support its inclusive genomics and RNA research program

As a McGill University spinout company, we at Molecular Forecaster are thrilled to support the recent landmark government investment into our alma mater through “DNA to RNA: An Inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R)”. The $165M investment, bolstered by another $185M+ commitment from academic and industrial partners will go towards supporting fundamental RNA research, including drug discovery efforts, which aligns perfectly with our company's mission and values.

NewsGuest UserMay 12, 2023BIOOQuébecmolecular forecaster, RNA technology, McGill University